Form 4: Boston Scientific Director Receives Equity Award

Boston Scientific Director David S. Wichmann was granted an annual equity award of 3,800 shares of common stock, vesting upon the next annual meeting.

Summary

• David S. Wichmann, a Director at Boston Scientific Corp., received an annual equity award on May 7, 2026.
• The award consists of 3,800 shares of common stock.
• This award is in the form of restricted stock that will vest in full upon the company's next annual meeting of stockholders.
• The reported value of the award is $215,000, based on the closing price of common stock on the grant date.
• Following this transaction, Mr. Wichmann beneficially owns 45,382 shares of common stock directly.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it reports a standard equity award to a director, which is a routine event for publicly traded companies and does not inherently signal positive or negative performance.

Positives

• Director David S. Wichmann received a significant equity award valued at $215,000, indicating continued investment in the company's leadership.
• The award is structured as restricted stock vesting upon the next annual meeting, aligning management's interests with long-term shareholder value.

Future Outlook

The restricted stock award is set to vest in full upon the next annual meeting of stockholders, indicating a future event tied to continued service and company performance.

Industry Context

StockSavvy.ai notes that equity awards to directors are a common practice in the medical device industry to incentivize long-term performance and align executive interests with shareholders. This award to a Boston Scientific director is consistent with industry norms for executive compensation.

Stakeholder Impact

• Shareholders: The equity award aligns director interests with long-term shareholder value, potentially leading to better strategic decisions. The increase in shares held by a director may be viewed positively.
• Employees: While not directly impacting employees, such awards can reflect a company culture that values long-term commitment and performance, which can indirectly influence employee morale.
• Management: The award serves as a form of compensation and retention for Director David S. Wichmann.

Next Steps

• The restricted stock award will vest in full upon the next annual meeting of stockholders.

Key Dates

Keywords

Boston Scientific, BSX, Form 4, Insider Trading, Equity Award, Restricted Stock, Director Compensation, Beneficial Ownership